Tag: EMA

Addressing Inadequate Worst-Case Selection During Inspection Readiness: A Practical Playbook In the pharmaceutical manufacturing landscape, the pressure of regulatory compliance and inspection readiness is ever-growing. One common shortfall observed during…

Strengthening CSV Compliance Throughout the Lifecycle to Prevent Validation Issues As pharmaceutical organizations strive to maintain GMP compliance, they often face challenges related to Computerized System Validation (CSV). Regular deficiencies…

Managing Requalification During Site Expansion: A Risk-Based Validation Approach In the dynamic landscape of pharmaceutical manufacturing, the process of site expansion presents unique challenges, particularly when it comes to maintaining…

“`html Addressing Inadequate Worst-Case Selection in Site Expansion: A Practical Playbook In the rapidly evolving landscape of pharmaceutical manufacturing, site expansions pose significant challenges, notably in ensuring appropriate validations are…

Addressing Validation Gaps Identified During System Upgrades to Mitigate Regulatory Deficiency Risks Pharmaceutical manufacturing is fraught with challenges, particularly when it comes to validation and regulatory compliance during system upgrades.…

“`html Managing Incomplete Validation Lifecycle During System Upgrades: A Comprehensive Playbook In the dynamic environment of pharmaceutical manufacturing, incomplete validation lifecycles during system upgrades can lead to compliance failures, resulting…

Addressing Validation Issues in Pharmaceutical Lifecycle Management for Enhanced Inspection Readiness Validation is a critical component of effective pharmaceutical manufacturing, ensuring that processes and products meet regulatory standards and quality…

Addressing Validation Gaps Identified During System Upgrades for Optimal Compliance In the fast-evolving landscape of pharmaceutical manufacturing, system upgrades are a necessity but often result in validation gaps that can…

Addressing Requalification Issues during Site Expansion to Mitigate Regulatory Risks As pharmaceutical manufacturing facilities expand, the urgency to maintain Good Manufacturing Practice (GMP) compliance increases, particularly concerning validation and requalification…

Aligning the Validation Lifecycle with Change Control: A Practical Playbook In the pharmaceutical manufacturing world, ensuring a complete and compliant validation lifecycle during change control is paramount for maintaining product…

Assessing Change Impact During System Upgrades: A Playbook for GMP Compliance In the dynamic landscape of pharmaceutical manufacturing, system upgrades are pivotal yet often overlooked for their potential impact on…

Managing Incomplete Validation Lifecycles in Pharmaceutical Operations Incomplete validation lifecycles can pose significant risks to pharmaceutical manufacturing operations, leading to potential regulatory non-compliance and gaps in product quality assurance. This…